Tumor necrosis factor receptor/tumor necrosis factor family members in antiviral CD8 T-cell immunity - PubMed (original) (raw)

Review

Tumor necrosis factor receptor/tumor necrosis factor family members in antiviral CD8 T-cell immunity

Shahram Salek-Ardakani et al. J Interferon Cytokine Res. 2010 Apr.

Abstract

CD8 memory T cells can play a critical role in protection against repeated exposure to infectious agents such as viruses, yet can also contribute to the immunopathology associated with these pathogens. Understanding the mechanisms that control effective memory responses has important ramifications for vaccine design and in the management of adverse immune reactions. Recent studies have implicated several members of the tumor necrosis factor receptor (TNFR) family as key stimulatory and inhibitory molecules involved in the regulation of CD8 T cells. In this review, we discuss their control of the generation, persistence, and reactivation of CD8 T cells during virus infection.

PubMed Disclaimer

Similar articles

• The contextual role of TNFR family members in CD8(+) T-cell control of viral infections.
  Wortzman ME, Clouthier DL, McPherson AJ, Lin GH, Watts TH. Wortzman ME, et al. Immunol Rev. 2013 Sep;255(1):125-48. doi: 10.1111/imr.12086. Immunol Rev. 2013. PMID: 23947352 Review.
• Regulation of CD4 T cell memory by OX40 (CD134).
  Salek-Ardakani S, Croft M. Salek-Ardakani S, et al. Vaccine. 2006 Feb 13;24(7):872-83. doi: 10.1016/j.vaccine.2005.07.108. Epub 2005 Sep 7. Vaccine. 2006. PMID: 16176850 Review.
• OX40 ligation of CD4+ T cells enhances virus-specific CD8+ T cell memory responses independently of IL-2 and CD4+ T regulatory cell inhibition.
  Yu Q, Yue FY, Gu XX, Schwartz H, Kovacs CM, Ostrowski MA. Yu Q, et al. J Immunol. 2006 Feb 15;176(4):2486-95. doi: 10.4049/jimmunol.176.4.2486. J Immunol. 2006. PMID: 16456009
• GITR ligand fusion protein agonist enhances the tumor antigen-specific CD8 T-cell response and leads to long-lasting memory.
  Durham NM, Holoweckyj N, MacGill RS, McGlinchey K, Leow CC, Robbins SH. Durham NM, et al. J Immunother Cancer. 2017 Jun 20;5:47. doi: 10.1186/s40425-017-0247-0. eCollection 2017. J Immunother Cancer. 2017. PMID: 28649380 Free PMC article.
• Costimulation signals for memory CD8+ T cells during viral infections.
  Duttagupta PA, Boesteanu AC, Katsikis PD. Duttagupta PA, et al. Crit Rev Immunol. 2009;29(6):469-86. doi: 10.1615/critrevimmunol.v29.i6.20. Crit Rev Immunol. 2009. PMID: 20121696 Free PMC article. Review.

Cited by

• The TNF family in T cell differentiation and function--unanswered questions and future directions.
  Croft M. Croft M. Semin Immunol. 2014 Jun;26(3):183-90. doi: 10.1016/j.smim.2014.02.005. Epub 2014 Mar 6. Semin Immunol. 2014. PMID: 24613728 Free PMC article. Review.
• The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in mice.
  Salek-Ardakani S, Flynn R, Arens R, Yagita H, Smith GL, Borst J, Schoenberger SP, Croft M. Salek-Ardakani S, et al. J Clin Invest. 2011 Jan;121(1):296-307. doi: 10.1172/JCI42056. Epub 2010 Dec 22. J Clin Invest. 2011. PMID: 21183789 Free PMC article.
• Comparison of Immune Responses in Pigs Infected with Chinese Highly Pathogenic PRRS Virus Strain HV and North American Strain NADC-20.
  Li X, Galliher-Beckley A, Wang L, Nietfeld J, Feng W, Shi J. Li X, et al. Open Virol J. 2017 Jun 30;11:73-82. doi: 10.2174/1874357901711010073. eCollection 2017. Open Virol J. 2017. PMID: 28839507 Free PMC article.
• Transcription Factor Bcl11b Controls Effector and Memory CD8 T cell Fate Decision and Function during Poxvirus Infection.
  Abboud G, Stanfield J, Tahiliani V, Desai P, Hutchinson TE, Lorentsen KJ, Cho JJ, Avram D, Salek-Ardakani S. Abboud G, et al. Front Immunol. 2016 Oct 13;7:425. doi: 10.3389/fimmu.2016.00425. eCollection 2016. Front Immunol. 2016. PMID: 27790219 Free PMC article.
• Combinatorial immunotherapy induces tumor-infiltrating CD8+ T cells with distinct functional, migratory, and stem-like properties.
  Van Braeckel-Budimir N, Dolina JS, Wei J, Wang X, Chen SH, Santiago P, Tu G, Micci L, Al-Khami AA, Pfister S, Ram S, Sundar P, Thomas G, Long H, Yang W, Potluri S, Salek-Ardakani S. Van Braeckel-Budimir N, et al. J Immunother Cancer. 2021 Dec;9(12):e003614. doi: 10.1136/jitc-2021-003614. J Immunother Cancer. 2021. PMID: 34903555 Free PMC article.

References

1. 1. Allam A, Conze DB, Giardino Torchia ML, Munitic I, Yagita H, Sowell RT, Marzo AL, Ashwell JD. The CD8+ memory T-cell state of readiness is actively maintained and reversible. Blood. 2009;114(10):2121–2130. - PMC - PubMed
2. 1. Amakawa R, Hakem A, Kundig TM, Matsuyama T, Simard JJ, Timms E, Wakeham A, Mittruecker HW, Griesser H, Takimoto H, Schmits R, Shahinian A, Ohashi P, Penninger JM, Mak TW. Impaired negative selection of T cells in Hodgkin’s disease antigen CD30-deficient mice. Cell. 1996;84(4):551–562. - PubMed
3. 1. Andreasen SO, Christensen JE, Marker O, Thomsen AR. Role of CD40 ligand and CD28 in induction and maintenance of antiviral CD8+ effector T cell responses. J Immunol. 2000;164(7):3689–3697. - PubMed
4. 1. Arribillaga L, Sarobe P, Arina A, Gorraiz M, Borrás-Cuesta F, Ruiz J, Prieto J, Chen L, Melero I, Lasarte JJ. Enhancement of CD4 and CD8 immunity by anti-CD137 (4–1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus. Vaccine. 2005;23(27):3493–3499. - PubMed
5. 1. Asprodites N, Zheng L, Geng D, Velasco-Gonzalez C, Sanchez-Perez L, Davila E. Engagement of Toll-like receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity. FASEB J. 2008;22(10):3628–3637. - PMC - PubMed

Publication types

MeSH terms

Substances

Grants and funding

• AI67341/AI/NIAID NIH HHS/United States
• R01 AI049453/AI/NIAID NIH HHS/United States
• R56 AI067341/AI/NIAID NIH HHS/United States
• U19 AI070535-040003/AI/NIAID NIH HHS/United States
• CA91837/CA/NCI NIH HHS/United States
• AI42944/AI/NIAID NIH HHS/United States
• AI070535/AI/NIAID NIH HHS/United States
• U19 AI070535/AI/NIAID NIH HHS/United States
• AI77079/AI/NIAID NIH HHS/United States
• R01 AI067341/AI/NIAID NIH HHS/United States
• R01 AI042944-10A2/AI/NIAID NIH HHS/United States
• R01 AI042944/AI/NIAID NIH HHS/United States
• AI49453/AI/NIAID NIH HHS/United States
• R01 CA091837/CA/NCI NIH HHS/United States
• R01 AI049453-08/AI/NIAID NIH HHS/United States
• R21 AI077079/AI/NIAID NIH HHS/United States
• R01 CA091837-07/CA/NCI NIH HHS/United States
• P01 AI089624/AI/NIAID NIH HHS/United States
• R01 AI067341-04/AI/NIAID NIH HHS/United States
• R21 AI077079-02/AI/NIAID NIH HHS/United States
• R01 AI087734/AI/NIAID NIH HHS/United States

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program